Clinical Trial Update: Inhaled Therapy Adherence and Outcomes to Kaftrio in Cystic Fibrosis

View source ↗

Summary

This completed clinical trial assesses adherence to inhaled Kaftrio (elexacaftor/tezacaftor/ivacaftor) in cystic fibrosis and the associated outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Kaftrio (elexacaftor/tezacaftor/ivacaftor)

Snippet

Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust | Conditions: Cystic Fibrosis | Status: COMPLETED